Amyloidogenicity of rodent and human βA4 sequences  by Dyrks, Thomas et al.
Volume 324, number 2, 231-236 FEBS 12584 
0 1993 Federation of European Biochemical Societies 00145793/93/$6.00 
Amyloidogenicity of rodent and human PA4 sequences 
June 1993 
Thomas Dyrks”, Elke Dyrksb, Colin L. Maste& and Konrad Beyreutherb 
“Research Laboratories of Schering AG, Berlin 65, Germany, ‘Center for Molecular Biology Heidelberg, University Heidelberg, 
Heidelberg, Germany and ‘Department of Pathology, University of Melbourne, Parkville. Victoria 3052, Australia 
Received 26 April 1993 
Previously we have shown that aggregation of the C-terminal 100 residues (A4CT) of the DA4 amyloid protein precursor (APP) and also of /?A4 
itself depends on the presence of metal-catalyzed oxidation systems [T. Dyrks et al. (1988) EMBO J. 7, 949-9571. We showed that aggregation of 
the amyloidogenic peptides induced by radical generation systems requires amino acid oxidation and protein cross-linking. Here we report that 
aggregation of A4CT and PA4 induced by radical generation systems involves oxidation of histidine, tyrosme and methionine residues. The rodent 
PA4 sequence lacking the single tyrosine and one of the three histidme residues of human PA4 and a /3A4 variant in which the tyrosme and the 
three histidine residues were replaced showed a reduced tendency for aggregation. Thus our results may explain why DA4 amyloid deposits could 
so far not been detected in the rodent brain. 
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1. INTRODUCTION 
Alzheimer’s disease (AD) is an irreversible neurode- 
generative disorder of the human central nervous sys- 
tem. The neuronal dysfunction is correlated with mas- 
sive deposition of fibrillar aggregates in the brain in the 
form of amyloid plaques [24]. These extracellular 
plaques consist mostly of a 4243 amino acid polypep- 
tide called the /?A4 peptide, which is derived from one 
or several larger transmembrane proteins, i.e. the 
(APPs) [5]. Similar deposits have been detected in aged 
monkeys, dogs, and polar bears [&lo], but rarely have 
they been found in rats and mice [ 111. The sequence of 
APP of mice [ 121 and rats [13], deduced from cDNA 
clones, are about 96% similar to the human APP protein 
[14]. Only three amino acid substitutions are found in 
the /3A4 region of rodents: Arg+Gly, Tyr+Phe and 
His+Arg at DA4 positions 5, 10 and 13, respectively. 
Proteolytic processing of amyloid protein precursors, 
leading to secretion of the extracellular part, occurs 
within the amyloid J3A4 sequence [15-l 71. This suggests 
that the N-terminus of the amyloid DA4 protein is not 
produced by the normal cleavage, which leads to secre- 
tory APP’s. How /3A4 is generated, and why its deposi- 
tion as amyloid is largely restricted to the brain, may 
involve a combination of altered APP processing and 
the unusual amyloidogenic properties of the human 
PA4 sequence [l&19]. 
Recent reports have shown that @-ACrelated pep- 
tides, corresponding to PA4 residues 140, are normally 
secreted by cultured cells and can be detected in human 
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cerebrospinal fluid [20-231. These PA4 related peptides 
are soluble and show no tendency for plaque formation 
or neurotoxicity. 
Here we show that PA4 and A4CT, an APP fragment 
which is likely to be an intermediate in the pathway 
leading to amyloid deposition [24], depend on amino 
acid oxidation and protein cross-linking to be amy- 
loidogenic. Furthermore, we demonstrate that within 
aggregated A4CT, histidine, tyrosine and methionine 
residues are oxidized by the metal-catalyzed oxidation 
systems. In addition we give evidence for a different 
aggregational behavior of the rodent /?A4 sequence. 
2. EXPERIMENTAL 
2.1. Clonrng procedures 
Preparation of plasmid DNA, restriction enzyme digestion, agarose 
gel electrophoresis of DNA, DNA ligation and bacterial transforma- 
tion were carried out as described by Sambrook et al. [25]. 
2.2. Plasmrd construction 
Construct SP65/A4CT and the prokaryotic expression vector NCO/ 
A4CT were constructed as described previously [26,27]. 
The constructions of SP65/j?A4, SP651/3A4rodent and SP65lBA4Hl 
Y were achieved by polymerase chain reaction (PCR) of the PA4 
sequence using APP695 cDNA as template. Oligonucleotides 5’pA4 
and 3’BA4 were used to amplify the human /?A4 sequence (codons 
5977638 of APP695 numbering is according to Kang et al. (51) starting 
with the methionine codon 596 as initiation codon. Ohgonucleotides 
pA4rodent and 3’/3A4 were used to amplify the rodent /?A4 sequence 
with the following substitutions Arg-601 +Gly. Tyr-606-+Phe and 
His-609+Arg. Oligonucleotides j?A4H/Y and 3’pA4 were used to 
amplify the H/Y PA4 sequence with substitutions of all three histidine 
residues and the tyrosme residue (His-602_tArg, Tyr-606+Phe. His- 
609+Arg and His-610-tArg). The oligonculeotide sequences are 
shown below. The amplified cDNAs were digested with EcoRIl 
Hind111 and subcloned into SP65/A4CTII. Plasmid SP65/A4CTII was 
obtained by cloning an oligonucleotide-linker (CATGCGGATC- 
CATGGATGCAGAATT) into SP65/A4CT. The resulting plasmids 
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were dtgested with BamHIIH~ndIlI and the BAl-sequences were 
cloned mto SP65 digested with the same enzymes. The resultmg m 
vitro expression vectors SP65/pA4. SP65/j?AJrodent and SP65/BA4Hl 
Y included methionme codon 596 of APP695 as mittation codon and 
the human, rodent or H/Y amyloid PA4 sequence (codons 597-638 of 
APP695) followed by a stop codon. 
The ohgonucleotides used were. 
5’PA4. GCAGAATTCCGACATGACTCAGG: 
3’PA4. CGATGAAGCTTACGCTATGACAACACCGCCCACC: 
PAlrodent. GCAGAATTCGGACATGACTCAGGATTTGAAGT- 
TCGTCATCAAAAATTGG. 
HIY/3A4. GCAGAATTCCGACGTGACTCAGGATTTGAAGTT- 
CGTCGTCAAAAATTGG. 
DNA templates (100 fig/ml) were transcribed in 40 mM Tris. pH 
7.5. 6 mM MgCI?. 2 mM spermidme, IO mM NaCI. IO mM DTT. 
RNasm (I umt/pl). l00~glml BSA. 500pM each ATP. CTP and LITP. 
50 ,uM GTP. and 500 ,uM m’G(5’)ppp(5’)G (Pharmacia. Freiburg. 
Germany). Typically. I unit of SP6 RNA polymerase (Boehrmger. 
Mannhelm. Germany) was added per ,ug DNA template for a 1 -hour 
synthesis at 40°C DTT and rNTPs stocbs were prepared with dteth- 
ylpyrocarbonate treated water The component, of the transcription 
reaction were mixed at room temperature to prevent precipitation of 
DNA. 
Followmg RNA synthesis. the DNA template was removed by the 
addition of RNase-free DNase and after a IO mm mcubatton at 37°C 
the reaction mixtures were phenol:chloroform extracted after addition 
of NaOAc (pH 5.2) to 0.3 M. The RNA was precipitated with ethanol 
and washed with 70% ethanol 
Translation of mRNA m a cell-free rabbit rrticulocyte Iysate or a 
wheat germ extract followed the procedures as described m the sup- 
pher’s manuals (Promega. Germany) Typically. the reactions were 
carried out for 60 mm at 30°C m the presence of 50 &I of 
[“S]methtonme and 0.5 -1 .O pg mRNA The translation mixture was 
diluted with 2 x Laemmh sample buffer After heatmg for 5 mm at 
1OO’C. labelled protems were analyzed by SDS-PAGE and fluorogra- 
phy with EN’HANCE (DuPont) 
The hemm stock solution was always freshly dissolved m 5 mM 
NaOH and centrifuged for IO mm at 12.000 x g The oxtdation reac- 
tion was performed in the presence of20pM hemln and I mM HZO,. 
or 0.5 mg/ml hemoglobin and 1 mM H201 m PBS at 37°C for I h. The 
reaction was termmated by the addition of 2 x Laemmli sample buffer 
(10% B-mercaptoethanol: see SDS-PAGE) and heatmg for 5 mm at 
I 00°C 
2.6. SDS-P.4GE 
Analysis of in vitro translated A4CT was by SDS-PAGE and ofpA 
peptides was by I6 5% Tris-trtcme gel separation [30]. The gels were 
analyzed by flourography with EN’HANCE (DuPont. Boston). 
Construction and expression of prokaryotic expression vektor 
NCO/A4CT were performed as described [26] 
A4CT was hydrolyzed with 6 N HCI/O.I% phenol for 20h by 110°C 
under Nz prior to analysis Quantitative ammo acids analysis was 
performed on an Applied Biosystems 130A1920A amino acid analyzer. 
For each analysts cahbration was done with a standard mixture of all 
amino acids (200 pmol). 
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3. RESULTS 
3.1. hhibitiorz oj‘ metal-catuljzed uggregation oj” A4CT 
Previously we showed that translation of A4CT in 
wheat germ extract results in a soluble non-aggregated 
protein which could be transformed to an aggregated 
molecule by incubation with hemoglobin/Hi,O, or other 
metal-catalyzed oxidation systems [26]. By the addition 
of amino acids, vitamin C, and the vitamin E derivative 
trolox we were able to inhibit the aggregation of A4CT. 
We suggested that the aggregation of A4CT induced by 
radical initiation systems may be due to the oxidation 
of amino acids and subsequent covalent cross-linking. 
To verify the latter assumption we tested the inhibitory 
potential of different amino acids on the aggregation 
process. 
For this purpose, A4CT was translated in the WG 
extract and incubated with hemoglobin/HzO, in the ab- 
sence or presence of different amino acids. Incubation 
of monomeric A4CT. translated in the WG extract, with 
hemoglobin/H,O, resulted in the previously-reported 
aggregation pattern of A4CT (Fig. 1, lane 2) [26]. Fig. 
1. lanes 3 to 13, shows that of the amino acids tested, 
only histidine and tyrosine showed a significant and 
reproducible inhibition of the aggregation. The same 
results were obtained if hemin/HzOz were used as the 
radical generation system (data not shown). 
3.2. Identl$cation of amino acids modiJied b?? metal-cat- 
oljzed o.uidution q’sterns 
To analyze the amino acid composition of the aggre- 
gated A4CT obtained in the presence of metal-catalyzed 
radical lreatment 
F C W K M L I T R ‘f H , -am,no acids 
12345678 91011 1213M KD 
69 
46 
Fig. 1. Inhibition of metal-catalyzed aggregation of A4CT by specific 
amino acids. A4CT mRNA was transcribed from the corresponding 
SP6 vector, translated m the WG extract m the presence of 
[‘Slmethtone, precipitated with TCA and after Incubation with or 
without 0 5 mg/ml Hb/l mM H,OZ and different ammo acids (30 
mmol). protems were analyzed by SDS-PAGE (12.5%). Lane 1. A4CT 
translated m the WG. precipitated with TCA and Incubated with PBS 
(0 2% SDS) for I h at 37°C; lane 2. same as lane I. but m the presence 
of 0.5 mg/ml Hb/l mM H,O,: lanes 3 to 13 same as lane 2. but in the 
presence of the indicated amino acids (30 mmol). M. molecular mass 
marker: KD. kilo dalton. 
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Table I 
Amino acid compositions of A4CT before and after radical treatment 
hem/H,O, _ + A4CTI 
A4CT + hem 
and the single tyrosine residue of human /?A4 respec- 
tively. SP65lPA4HIY codes for a DA4 sequence in which 
all three histidine residues are substituted with arginine 
and the single tyrosine with phenylalanine (Scheme 1). 
Amino acid 
D 6,47 f 1.75 5,73 + 1,87 1,13 
E 15,71 f 4,16 13,37 f 2,80 1.18 
S 5,81 f 0,54 7.26 + 1,08 0,80 
G 11.96 f 3.89 17,13 f 4.42 0,70 
H 3,61 + 0,91 1,46 t 1.17 2,41 
R 4,07 f 0,24 4.67 III 0,63 0,87 
T 5,25 f 0,38 5,53 * 0.34 0,95 
A 9,06 f 0,74 9.23 + 0,54 0,98 
P 3,07 + 0,47 3,50 + 0,62 0,88 
Y 3,68 + 0.45 1,52 + 0.94 2,43 
V 8,33 f. 2,lO 8,35 + 1.12 1 ,oo 
M 0,21 t 0,lO 0,07 + 0,lO 2,99 
I 4,Ol f. 0,93 3,27 + 1.66 1.23 
L 7,65 + 1,07 8,62 + 0.97 0,89 
F 4,79 + 0,48 4,60 + 0.51 1,04 
K 6,ll f 0.60 5,41 * 0.79 1,13 
Data are the means + S.D. of six experiments in mol% amino acid. 
To determine whether the different amino acid substi- 
tutions have any effect on the aggregation properties of 
PA4 induced by metal-catalyzed oxidation systems, we 
incubated the corresponding peptides, PA4human. 
pA4rodent, and pA4HIY translated in the WG extract 
with the same radical generating systems as described 
previously [26]. 
Fig. 3, lanes 1 to 3, shows translations of the different 
PA4 sequences in the WG extract and analysis by Tris- 
tricine SDS-PAGE. Incubation of monomeric 
PA4human, translated in the WG extract. with hemo- 
globin/H,O, resulted in the previously-reported aggre- 
gation pattern including three prominent bands at 4 
kDa, 19 kDa and 46 kDa (Fig.4, lane 4). In contrast, 
the PA4rodent peptide and the PA4HN peptide show 
a clear and reproducible decrease of the aggregational 
bands at around 19 kDa and 46 kDa. The same results 
are obtained if hemin/H,O, are used as radical genera- 
tion system (data not shown). 
oxidation systems, purified bacterial-expressed A4CT 
was incubated with and without hemin/H,O, and the 
amino acid composition was analyzed by amino acid 
analysis. Table I shows the means + SD of six experi- 
ments in mol% amino acid. After the radical treatment 
a significant decrease in mol% amino acid is only seen 
for histidine, tyrosine and methionine. Fig. 2 shows the 
quotient of mol% amino acid of untreated A4CT and 
A4CT after radical treatment. It is obvious that only 
hi&dine, tyrosine and methione are oxidized by the 
radical treatment. 
Densiometric measuring of the major aggregates in 
Fig. 3, lanes 4, 5 and 6, shows a 4- to 5-fold decrease 
for PA4HN and PA4rodent aggregates in relation to 
the human sequence (Fig.4). This provides good evi- 
dence that the hi&dine and/or tyrosine residues of the 
PA4 sequence are responsible for the aggregation be- 
havior of this amyloidogenic peptide. 
4. DISCUSSION 
3.3. Aggregation behavior of different PA4 sequences 
Because the inhibition assay and the amino acid anal- 
ysis of oxidized A4CT strongly suggest that aggregation 
of A4CT is induced by oxidation of hi&dine, tyrosine 
and methionine, we analyzed whether substitution of 
some or all of these amino acids in the /?A4 sequence 
had any effect on the aggregation properties of pA4. 
Therefore we constructed SP65lpA4rodent and SP65lHl 
Y, in addition to SP65lPA4, which codes for the human 
/3A4 sequence. SP65lpA4rodent codes for the rodent 
PA4 sequence, which shows three amino acid substitu- 
tions, two of which change one of the three histidines 
Previously, we have presented experimental evidence 
that A4CT and /?A4 are soluble and non amyloidogenic 
APP fragments. Both peptides, if expressed in the wheat 
germ translation system and analyzed by SDS-PAGE, 
resulted in only monomeric forms. Furthermore, we 
were able to transform monomeric A4CT and PA4 into 
aggregating amyloidogenic molecules by the addition of 
metal-catalyzed oxidation systems. This transformation 
could be inhibited by the addition of radical scavengers 
such as vitamin C, vitamin E analogue trolox and 
amino acids. We suggested that the aggregation of 
A4CT and DA4 requires amino acid oxidation and pro- 
tein cross-iinking induced by 
terns. 
Rodent GGA TTT CGA 
Human GAT GCAGAATTC CGACATGAC TCAGCATATGAAGTT CATCATCAAAAA 
Human D A E F R H D S G Y E V H H Q K 
Rodent G - - - - F - - R - - - 
H/Y R---P--RR-- 
radical generation sys- 
Scheme 1. SchematIc diagram of the different PA4 sequences used in this study. Line 1 shows the rodent 
BACDNA sequence at codons where substitutions occur. Line 2 shows the human j?A4 DNA sequence from 
Asp-597 to Lys-612 (numbering is according to [5]). Lines 3 to 5 represent the amino acid sequences in one letter 
code of /?A4human, the j?A4rodent and pA4HN form Asp-597 to Lys-612. 
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A4CT I A4CT + hem 
D E S G H R T A P Y V M I L F K 
Fig. 2. Modtficatton of the ammo actd composttion of A4CT by oxygen radicals. 500 pmol of purified bacterial A4CT was incubated with or without 
20pM hemm/l mM H20, for 90 mm. prectpitated wtth methanol/chloroform and hydrolyzed wtth 6 N HCl/ 0.1% phenol for 20 h at 110°C under 
N2, Amino acid analysts was performed on an Apphed Btosystems amino acid analyzer The ordmate presents the quottent of mol% amino acrd 
of untreated A4CT and mol% amino acid of A4CT incubated with hem/HZ02. 
_ _ _ + + + 
KD 1 2 3 4 5 6 
46 
30 
19 
16 
6 
r 
Hb 
Fig. 3. Aggregatton behavior of different /?A4-sequences. Translation 
was as described in Fig 1. The dtffcrent PA4 pepttdes were expressed 
in the WC extract. prectpnated with TCA. and after mcubatton with 
0.5 mg/ml Hb/l mM HIO,, pepttdes were analyzed by Trts-trrctne 
SDS-PAGE (16.5%). Lanes 1, 2 and 3, bA4human. PA4rodent and 
PA4HN Incubated with PBS (0.2% SDS) for 1 h at 37°C: lane3 4. 5 
and 6, same as lanes 1.2 and 3. but in the presence of 0.5 mg/ml Hb/l 
mM H,O,: KD. ktlo dalton 
To verify this. in the work reported here we have 
tested the inhibitory potential of different amino acids 
on the aggregation process. The specific inhibition of 
the aggregation by histidine and tyrosine strongly sup- 
ports the idea that amino acid oxidation is involved in 
the PA4 aggregation process. Both amino acids are 
known to be particularly sensitive to modification by 
hydroxyl radicals [31]. 
Furthermore. direct evidence for the oxidative dam- 
age of these amino acids has been obtained by amino 
acid analysis of modified bacterial A4CT. Only 
methionine, histidine and tyrosine showed a 2- to 3-fold 
decrease after radical treatment. 
From these results we suggest that those amino acids 
which are modified by the radical attack should also be 
necessary for the aggregation process. Substitution of 
these residues should lead to a peptide which is resistant 
to free radical-induced transformation into an aggre- 
gated molecule. 
In the context of the on going discussion of whether 
the rodent /JA4 sequence has an altered conformation 
and aggregational behavior, we analyzed the rodent 
PA4 sequence (jIA4rodent) which contains three substi- 
tutions, two of which change histidine and tyrosine res- 
idues, and also a human PA4 sequence @A4HIY) with- 
out any histidine and tyrosine in our aggregation assay. 
We show that in the presence of radical generating sys- 
tems there is a significant difference between the aggre- 
gational properties of the wild type human and the ro- 
dent PA4 sequences. Under the conditions used, only 
the human PA4 sequence shows a strong tendency to 
form higher aggregates. Thus in the presence of biolog- 
ical active radicals, only the human PA4 sequence was 
highly amyloidogenic. Because in addition the human 
PA4 sequence without histidine and tyrosine residues 
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18,00 
16,OO 
8 14,OO 
.s 12,00 
r 
*%J 10,oo 
s 
.E 8,00 
= 
E 
P 
6,00 
* 4,00 
4 kDa 19 kDa 32 kDa 
Human 100 13,61 17,33 
Rodent 100 2.82 4,41 
H/Y 100 I,35 3.42 
human rodent H/Y 
Fig. 4. Denstometric measuring of the major aggregates presented in Fig. 3. The autoradiography was analyzed by scanning densitometry (Elsscript 
400, Hirschmann) and the area of the signals are calculated (HlD-Calculationprogram. Hirschmann). The data represent the signal-intensity m 
percent of the 4 kDa signal (100%). The values are normalized to the 4 kDa band. 
shows a further decrease in aggregation tendency in the 
presence of radicals, we suggest that the difference be- 
tween aggregational behavior of the rodent and human 
sequence is based on the different content of histidine 
and tyrosine residues. 
Our results are not in conflict with previously pub- 
lished data giving evidence that the human j3A4 peptide, 
but not the rodent homologue, is capable of forming a 
p-pleated sheet structure at a low peptide concentration. 
Otvos et al. have already suggested that subtle interspe- 
ties amino-acid differences may account for the inabil- 
ity of the rodent peptide to form amyloid fibrils in situ 
[32]. In contrast, other results showed no difference in 
solubility and secondary structure of the full- and 
shorter sized A4 peptides derived from humans and 
rodents [14]. The latter studies however, did not take 
into account the effects of varying environmental fac- 
tors such as radical attack which may contribute to the 
deposition process of the solublePA peptide into insol- 
uble fibrils. We propose that radical attack cross-links 
and stabilizes already-preformed PA4 tetramers, which 
then may be able to aggregate further. We show here 
that the substitutions in the rodent sequence are respon- 
sible for the reduction in protein cross-linking by amino 
acid oxidation but they also may be responsible for 
differences in the P-pleated sheet-forming ability of the 
/3A4 peptide at low concentrations [32]. 
The results presented here provide further evidence 
for our previous suggestion that amino acid oxidation 
by metal-catalyzed oxidation systems is required to ini- 
tiate /?A4 aggregation in vitro and in Alzheimer’s dis- 
ease. The aggregation of PA4 or APP-fragments in- 
duced by radical attack may therefore be the primary 
event that leads to amyloid formation. After generation 
of a core of cross-linked amyloidogenic fragments, fur- 
ther APP-fragments may extend the deposition without 
involvement of metal-catalyzed oxidation systems. Fur- 
thermore we provide important clues as to why humans 
and animal species expressing the human PA4 sequence, 
but not rodents, are capable of forming amyloid fibrils 
in the brain. 
Acknowledgments. We thank Santo Pinto for technical assistance 
with the Applied Biosystem amino acid analyser. This work was sup- 
ported by grants from the Deutsche Forschungsgemeinschaft through 
SFB 3 17 and 258. the Bundesminister fur Forschung und Technologie 
of Germany, the Metropolitan Life Foundation. the Thyssen Sttftung, 
the Fonds der Chemischen lndustrte of Germany, the Forschungs- 
schwerpunkt Baden-Wurttemberg. 
REFERENCES 
111 
[II 
I31 
141 
151 
PI 
[71 
PI 
[91 
VOI 
illI 
[I21 
u31 
Dyrks, T., Wetdemann. A., Multhaup. G.. Salbaum .J.M.. Le- 
man-e. H.-G.. Kang. J.. Miiller-Hill. B., Masters, CL. and 
Beyreuther. K. (1988) EM90 J. 7, 949-957. 
Glenner, G.G. and Wong, C.W. (1984) Biochem. Biophys. Res. 
Commun. 120, 8855890. 
Masters. C.L., Stmms, G., Wemmann, N.A.. Multhaup, G., Mc- 
Donald, B.L. and Beyreuther, K. (1985) Proc Natl. Acad. Sci. 
USA 82, 42454249. 
Masters, C.L., Muhhaup, G., Simms, G., Pottgtesser. J., Martins, 
R.N. and Beyreuther, K. (1985) EMBO J. 4, 2757-2763. 
Kang. J.. Lemaire. H.-G., Unterbeck, A., Salbaum, J.M., Mas- 
ters, C.L.. Grzeschtk. K.-H., Multhaup, G.. Beyreuther, K. and 
Mdller-Htll. B. (1987) Nature 325. 7333736. 
von Brdunmuhl. A. (1956) Arch. Psychtatr Z. Neurol. 194. 396 
414. 
Struble, R.G., Price, D.L. Jr.. Cork, L.C. and Price, D.L. (1985) 
Brain Res. 361, 2677275. 
Wismewski. H M., Johnson, A.B.. Raine, C.S.. Kay, W.J and 
Terry, R.D (1970) Lab. Invest, 23, 287-296. 
Price. D.L. (1986) Annu. Rev. Neurosct. 9. 4899512. 
Selkoe, D.J., Bell, D.S., Podlisny. M.B.. Prtce. D.L. and Cork, 
L.C. (1987) Science 235, 873-877. 
Selkoe, D.J. (1989) Annu. Rev. Neurosci. 12, 463490. 
Yamada. T.. Sasakt. H.. Furuya, H., Miyata. T., Goto. I. and 
Sasaki. Y. (1987) Btochem. Biophys Res. Commun. 149, 6655 
671. 
Shivers, B.D., Hilbtch, C.. Multhaup, G., Salbaum, M.. 
Beyreuther, K. and Seeburg. P.H. (1988) EMBO J. 7, 13655 
1370). 
235 
Volume 324. number 2 FEBS LETTERS June 1993 
[14] Hilbtch, C., Krsters-Wotke, B.. Reed J., Masters C L. and 
Beyreuther K. (1991) Eur. J. Biochem. 201, 61-69. 
[15] Weidemann. A., Komg. G., Bunke, D., Fischer, P., Salbaum, 
J.-M., Master, C.L. and Beyreuther. K. (1989) Cell 57, 115-126. 
[16] Stsodia. S.S , KOO, E.H., Beyreuther, K.. Unterbeck. A and 
Price, D.L. (1990) Sctence 248, 492495. 
[17] Esch, F.S., Keim, P.L. Beattte, E.C., Blather, R.W . Culwell, 
A.R.. Oltersdorf. T.. McClure. D. and Ward.P.J. (1990) Science 
248, 1122-t 124 
[IS] Hilbich C.. Ktsters-Woike. B., Reed, J., Masters, C.L and 
Beyreuther, K. (1991) J. Mol. Biol. 218. 149-163. 
[19] Burdock. D., Soreghan. B., Kwon, M.. Kosmoski. J., Knauer. M.. 
Henschen. A., Yates. J.. Cotman. C. and Glabe. C. (1992) J. B~ol. 
Chem 267. 5466554. 
[20] Haass, C., Schlossmacher, M.G.. Hung. A.Y., Vigo-Pelfrey. C , 
Mellon. A., Ostaszewski, B.L.. Liebergurg. I.. Koo, E.H., 
Schenk, D., Teplow, D B. and Selkoe, D.J. (1992) Nature 359. 
322p 325. 
[21] Seubert, P. Vigo-Pelfrey. C.. Esch, F., Lee, M.. Dovey, H , 
Davis, S . Smha, S , Schlossmacher, M., Whaley. J.. Swm- 
dlehurst, C., McCormack. R.. Wolfert, R , Selkoe. D , Lteber- 
burg. I. and Schenk, D (1992) Nature 359, 3255327. 
[23] ShoJi, M.. Golde. T.E., Ghiso, J., Cheung, T.T. Estus. S . Shaf- 
fer, L.M., Cai, X.-D., McKay. D.M., Tmtner. R., Frangtone. B. 
and Younkin, S.G. (1992) Science 258, 1266129. 
[23] Busctgho, J.. Gabuzda. D.H., Matsudana. P. and Yankner. B.A. 
(1993) Proc. Natl. Acad. SCI. USA 90, 2092-2096. 
[24] Estus. S., Golde. T.E., Kunishtta. T.. Blades, D., Lowery. D.. 
Eisen, M.. Ustak, M.. Qu. X., Tabira, T., Greenberg, B.D. and 
Younkin. S.G. (1992) Science 255. 726728. 
[25] Sambrook, J.. Frttsch, E.F and Maniatis. T. (1989) Molecular 
Clonmg: A Laboratory Manual, 2nd edn., Cold Sprmg Harbor 
Laboratory Press. New York. 
[26] Dyrks, T., Dyrks. E.. Hartmann. T., Masters, C.L. and 
Beyreuther, K. (1992) J. Biol. Chem. 267. 18210~18217. 
[27] Dyrks. T.. Dyrks E.. Masters C.L. and Beyreuther K (1992) 
FEBS 309, 20-24. 
[28] Konarska. M M , Padgott. R.A. and Sharp, P.A. (1984) Cell 38, 
731-736. 
[29] Solar, I.. Duhtzky. J.. and Shaklat. N. (1990) Arch. Btochem. 
Btophys 283, 81-89 
[30] SchHgger. H. and Von Jagow, G (1987) Anal. Btochem 166. 
3688379. 
[31] Davtes, K.J.A.. Delstgnore. M.E. and Lin. S.W. (1987) J. Biol. 
Chem. 262. 990229907. 
[32] Otvos, Jr..L., Szendrer, G.I., Lee, VM.-Y. and Mantsch, H.H. 
(1993) Eur J. Biochem. 221. 249-257 
236 
